In the Communications of the German Society of Nephrology, the current status of clinically applicable biomarkers in the context of chronic kidney disease was presented with a focus on early detection, prognosis, and differential diagnosis. Based on two recently published review articles from the UPTAKE consortium on non-invasive biomarkers for chronic kidney disease patient management, a prominent role of multiple applications of Mosaiques’ biomarkers and technology was presented.

Both articles are available online in the "International Journal of Molecular Science" at https://www.mdpi.com/1422-0067/25/7/3678 and https://www.mdpi.com/1422-0067/25/6/3519 respectively.